SARS-CoV-2 Helicase Targeted Library

Summary of the technology

The offer SARS-CoV-2 Helicase (NSP13) Targeted Library, which contain 1170 compounds with predicted activity against this vital protein. The overall procedure included accurate flexible docking of Drug-like Green Collection into helicase active site.

Covid-19 Innovation Challenges by Innoget

Details of the Technology Offer

We offer a target library of SARS-CoV-2 Helicase (NSP13), which contains 1170 compounds with predicted activity on helicase SARS-CoV-2 (non-structural protein 13, NSP13), which is important for coronavirus replication. It separates double-stranded RNA (dsRNA). The identification of small molecules for which the replication apparatus is a target has shown the highest potential for the detection of antiviral drugs.

The library was developed based on virtual screening receptors using a homologous model of SARS-CoV-2 NSP13. Final selection of compounds was performed based on key structural determinants of the enzymatic active site for ligand binding, scoring, and intermolecular hydrogen bonds with key amino acid residues of the active site.

Related Keywords

  • Applications for Health
  • Biological Sciences
  • Medicine, Human Health
  • Biostatistics, Epidemiology
  • Diagnostics, Diagnosis
  • Medical Research
  • Human vaccines
  • Emergency Medicine Technology
  • Genetic Engineering Technology
  • Infectious Diseases
  • Medical/health
  • Genetic Engineering / Molecular Biology
  • Genetic Engineering Market
  • Medical Health related
  • Diagnostic
  • Diagnostic services
  • Covid-19
  • compounds
  • coronavirus
  • sars-cov-2

About Covid-19 Innovation Challenges by Innoget

Ahead of the current Coronavirus outbreak, Innoget is fully committed to contributing to mobilizing scientific and expert communities to find a real solution to the Covid-19 pandemic. Therefore, we're supporting worldwide calls and programs that could help in any aspects of the coronavirus crisis.

Is your organization promoting or looking for innovation or research initiatives to mitigate the Covid-19 outbreak? Email us at covid19@innoget.com to list them.

Channeled through Innoget's online open innovation network, initiatives in the health, virology, medicine, or novel technologies applied to human health, among others, are listed and disseminated to Innoget members -ranging from hospitals, research institutes, scientists, businesses, and public administrations- and innovation partners worldwide.

Covid-19 Innovation Challenges by Innoget

Never miss an update from Covid-19 Innovation Challenges by Innoget

Create your free account to connect with Covid-19 Innovation Challenges by Innoget and thousands of other innovative organizations and professionals worldwide

Covid-19 Innovation Challenges by Innoget

Send a request for information
to Covid-19 Innovation Challenges by Innoget

Submit your request

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support